Digital Health Late Stage Investors & VC Firms
327 firms in this list, with a median first check of $1.1M. 99 of them lead rounds. Generated from verified public data and updated continuously.
DeepTech & Climate Fonds
MunichSeed–Late Stage$5.5M – $55M
3 people
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
8 people
Kinnevik
StockholmSeed–Late Stage
Pivotal bioVenture Partners
San FranciscoSeed–Late Stage
12 people
Almeda Ventures
Tel AvivSeed–Late Stage
11 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
8 people
20/20 HealthCare Partners LLC
AuburndaleSeed–Late Stage
7 people
Invest Tech
São PauloPre-Seed–Late Stage
4 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
Ming capital
ShenzhenSeed–Late Stage
6 people
Gruppo Bertoldi
TrentoSeed–Late Stage
2 people
Avestria Ventures
San FranciscoPre-Seed–Late Stage
4 people
Marathon Venture Partners
Pre-Seed–Late Stage
Rock Springs Capital
BaltimoreLate Stage
12 people
Vesalius Biocapital III Partners SàRL
ConternSeed–Late Stage$10.8M
12 people
Utiliti Group
SydneySeed–Late Stage
OSK Ventures International
Kuala LumpurSeed–Late Stage$1.3M – $6.1M
OCV Partners
Los AngelesPre-Seed–Late Stage
5 people
Vesalius Biocapital Partners
LuxembourgSeed–Late Stage$11M
5 people
Endeavour Vision
GenevaLate Stage
6 people
Finchley Healthcare Ventures
MontrealSeed–Late Stage
11 people
naturalX Health Ventures
KarlsruheSeed–Late Stage$3.2M – $5.4M
5 people
Syridex Bio
PrincetonPre-Seed–Late Stage
11 people
iNetworks
PittsburghSeed–Late Stage
9 people
Related lists
Late Stage Investors & VC Firms (2864)Digital Health Investors & VC Firms (1179)Late Stage Investors & VC Firms in United States (1101)Digital Health Seed Investors & VC Firms (966)Digital Health Series A Investors & VC Firms (890)Late Stage Investors & VC Firms in Global (857)Healthtech Late Stage Investors & VC Firms (847)Enterprise Software Late Stage Investors & VC Firms (801)SaaS Late Stage Investors & VC Firms (784)Digital Health Investors & VC Firms in United States (692)
Data sourced from public filings and firms' own websites — see our methodology.
























































